Today: 21 May 2026
PennyMac Investor Probe Deepens After 33% Stock Plunge: What PFSI Holders Need To Know
30 April 2026
2 mins read

PennyMac Investor Probe Deepens After 33% Stock Plunge: What PFSI Holders Need To Know

NEW YORK, April 30, 2026, 09:02 EDT

  • Rosen Law Firm is moving to file a class action targeting PennyMac Financial Services, aiming to recoup losses for investors following the company’s earnings release in January.
  • Schall Law Firm has launched its own probe into whether PennyMac gave investors inaccurate or incomplete information, or left out details that mattered.
  • PennyMac’s servicing segment took a sharp hit in the fourth quarter, with pretax income dropping to $37.3 million—down from $157.4 million just one quarter earlier.

PennyMac Financial Services Inc. is back under the microscope after its shares tumbled 33.3% in a single day following its January earnings report. Now, two shareholder law firms are ramping up pressure on the mortgage lender, zeroing in on the company’s servicing business.

Rosen Law Firm on Wednesday said its investigation into potential securities claims is ongoing, and it’s putting together a class action for investors hit with losses. The same day, Schall Law Firm issued its own notice, stating it’s probing whether PennyMac made misleading statements or left out key information investors should have known.

PennyMac’s timing couldn’t be much worse. These notices landed just days ahead of its first-quarter earnings report, expected after the bell on May 5—an update investors will be combing for any hint that the servicing setback is letting up.

Mortgage servicing rights—MSRs—are the real issue in play here: they grant firms the right to collect a stream of fees for processing mortgage payments. But when homeowners refinance or pay off their loans ahead of schedule, that fee income can drop off. On Jan. 29, PennyMac reported a 70% plunge in pretax income for its servicing segment (excluding valuation items) from the previous quarter. The culprit? A spike in MSR cash flow realization, with lower mortgage rates fueling more prepayments.

PennyMac didn’t turn in a uniformly soft fourth quarter. Net income came in at $106.8 million, or $1.97 a share diluted, with total net revenue at $538.0 million. The production segment actually saw pretax income climb to $127.3 million from $122.9 million the previous quarter.

Servicing was the story behind the market’s move. Pretax income from that segment slipped to $37.3 million—down sharply from $157.4 million in the third quarter and $87.3 million for the same period last year. Rosen noted PennyMac shares dropped $49.78, finishing at $99.92 on Jan. 30 after the news hit.

David Spector, chairman and CEO, pointed to “strong production results” in the January statement, but noted that “increased runoff on our MSR asset” cut into that performance as prepayment speeds picked up. Spector added that for the full year 2025, the company booked double-digit earnings growth in both of its operating segments. PennyMac Financial Services, Inc.

Competition’s heating up, too. On the earnings call, Spector noted PennyMac saw higher lock volumes after rates dipped early on, but pointed out that “excess capacity has created a more competitive origination market,” according to HousingWire. HousingWire

PennyMac isn’t the only one feeling it. Rocket Companies, which finished its Mr. Cooper buyout on Oct. 1, 2025, reported mortgage servicing rights worth $19.44 billion at year-end—up sharply from $7.63 billion the previous year. The jump explains why servicing assumptions get heavy scrutiny from investors watching nonbank mortgage lenders.

One thing to note: these are legal inquiries, not verdicts. The law firm alerts amount to investigations or offers to represent, not conclusions about blame. Rosen laid out a potential class action; Schall mentioned it’s still looking into the claims. Neither announcement proves liability on its own.

PFSI closed out Wednesday at $89.18, well off the $99.92 mark from after the January downturn. Now, all eyes turn to next week’s report, when PennyMac will have to prove production growth can counter choppy servicing results—and do it without eating into margins.

Stock Market Today

  • Asian Shares Rise on Oil Price Drop and Nvidia's Strong AI-Driven Earnings
    May 21, 2026, 1:31 AM EDT. Asian shares surged Thursday, led by South Korea's Kospi gaining 8%, following Wall Street's AI-driven rally and easing bond market pressure. Nvidia's quarterly profit jumped over 200%, fueled by demand for its AI chips, boosting tech stocks like Samsung Electronics, which rose 7.5%, and SK Hynix, up 11.3%. Taiwan's Taiex added 3.9%, supported by TSMC's 3% increase. Japan's Nikkei climbed 3.6% aided by a 15% rise in exports. Oil prices fell sharply, with Brent down 5%, arousing hopes of renewed U.S.-Iran oil supply talks, before a partial rebound. U.S. stocks also recovered, with the S&P 500 up 1.1% as 10-year Treasury yields eased, reducing pressure on equities amid inflation and interest rate concerns.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Eli Lilly Raises 2026 Forecast as Mounjaro, Zepbound Sales Keep Weight-Loss Boom Alive
Previous Story

Eli Lilly Raises 2026 Forecast as Mounjaro, Zepbound Sales Keep Weight-Loss Boom Alive

FuelCell Energy Stock Jumps as AI Power Boom Puts FCEL Back in Play
Next Story

FuelCell Energy Stock Jumps as AI Power Boom Puts FCEL Back in Play

Go toTop